DHEA treatment

DRUG2 trials

Sponsors

University Hospital, Bordeaux

Conditions

Chronic Obstructive Pulmonary DiseaseHypertension, Pulmonary

Phase 2

Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults (DHEA-HTAP)

CompletedNCT01273259

University Hospital, BordeauxChronic Obstructive Pulmonary Disease, Hypertension, Pulmonary

Start: 2008-05-06End: 2015-06-05Updated: 2026-06-11

Phase 3

Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults

CompletedNCT00581087

University Hospital, BordeauxChronic Obstructive Pulmonary Disease, Hypertension, Pulmonary

Start: 2007-01-01End: 2015-06-01Target: 60Updated: 2026-06-10

Related Papers

Dehydroepiandrosterone (DHEA) improves pulmonary hypertension in chronic obstructive pulmonary disease (COPD): a pilot study.

2012-01-2645 citations